Previously described lncRNA MEG3 was also suggested to be a potential therapeutic target in osteosarcoma due to its negative regulation of the well-known oncogene FOXM1 through sponging miR-361-5p (Shen et al., 2019). This evidence concerns the gene FOXM1 and osteosarcoma.